ATE516040T1 - Zusammensetzung und verwendung zur vorbeugung oder behandlung von stomatitis - Google Patents
Zusammensetzung und verwendung zur vorbeugung oder behandlung von stomatitisInfo
- Publication number
- ATE516040T1 ATE516040T1 AT05794086T AT05794086T ATE516040T1 AT E516040 T1 ATE516040 T1 AT E516040T1 AT 05794086 T AT05794086 T AT 05794086T AT 05794086 T AT05794086 T AT 05794086T AT E516040 T1 ATE516040 T1 AT E516040T1
- Authority
- AT
- Austria
- Prior art keywords
- composition
- preventing
- treating stomatitis
- pharmaceutically acceptable
- stomatitis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Confectionery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Jellies, Jams, And Syrups (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60705304P | 2004-09-03 | 2004-09-03 | |
| PCT/US2005/031364 WO2006028991A2 (en) | 2004-09-03 | 2005-09-02 | Composition and method for prevention or treatment of stomatits |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE516040T1 true ATE516040T1 (de) | 2011-07-15 |
Family
ID=36036881
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05794086T ATE516040T1 (de) | 2004-09-03 | 2005-09-02 | Zusammensetzung und verwendung zur vorbeugung oder behandlung von stomatitis |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8067537B2 (de) |
| EP (1) | EP1789068B1 (de) |
| JP (1) | JP5066448B2 (de) |
| CN (1) | CN101027078B (de) |
| AT (1) | ATE516040T1 (de) |
| CA (1) | CA2578748C (de) |
| HK (1) | HK1099918A1 (de) |
| WO (1) | WO2006028991A2 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5408882B2 (ja) * | 2008-01-23 | 2014-02-05 | ヤマサ醤油株式会社 | 唾液分泌促進剤 |
| MY177473A (en) | 2013-01-21 | 2020-09-16 | Kyowa Hakko Bio Co Ltd | Agent for elevating nitric oxide concentration |
| JP6582983B2 (ja) * | 2013-07-31 | 2019-10-02 | 味の素株式会社 | 癌化学療法時の副作用軽減剤 |
| EP3006045B3 (de) | 2014-10-07 | 2021-03-17 | Cyprumed GmbH | Pharmazeutische Formulierungen zur oralen Verabreichung von Peptid- oder Proteinarzneimitteln |
| US20160367620A1 (en) | 2015-06-19 | 2016-12-22 | Harry B. Demopoulos | Glutathione |
| WO2017060500A1 (en) | 2015-10-07 | 2017-04-13 | Cyprumed Gmbh | Pharmaceutical formulations for the oral delivery of peptide drugs |
| US10646487B2 (en) | 2016-07-14 | 2020-05-12 | Showa Denko K.K. | Melanin production inhibitor, whitening agent, fibroblast activator, collagen and/or elastin production promotor and wrinkle ameliorant |
| EP3622957A4 (de) * | 2017-05-12 | 2021-01-27 | Furukawa Research Office Co., Ltd. | Mittel zur verbesserung der arteriellen sauerstoffsättigung |
| JP2021161045A (ja) * | 2020-03-31 | 2021-10-11 | 株式会社古川リサーチオフィス | 亜鉛化合物配合組成物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2250553A (en) * | 1938-04-18 | 1941-07-29 | Simon L Ruskin | Medicinal preparation |
| DE3011437A1 (de) * | 1980-03-25 | 1981-10-01 | Hrvoje Dr. Zagreb Krnjevic | Pharmazeutisches mittel zur heilung von entzuendlichen und/oder degenerativen und/oder atrophischen schleimhauterkrankungen |
| US4508898A (en) * | 1980-09-16 | 1985-04-02 | Ogilvie Kelvin K | Antiviral triazine compounds |
| US4975434A (en) * | 1986-05-27 | 1990-12-04 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Antiviral and anticancer cyclopentenyl cytosine |
| US5204114A (en) | 1992-03-30 | 1993-04-20 | Health Maintenance Programs, Inc. | Methods of manufacturing high dosage glutathione the tablets and capsules produced thereby |
| US5686436A (en) * | 1993-05-13 | 1997-11-11 | Hiv Diagnostics, Inc. | Multi-faceted method to repress reproduction of latent viruses in humans and animals |
| GB9620504D0 (en) * | 1996-10-02 | 1996-11-20 | Boehringer Ingelheim Ltd | Compositions |
| US6350467B1 (en) * | 1996-12-31 | 2002-02-26 | Antioxidant Pharmaceuticals Corp. | Pharmaceutical preparations of glutathione and methods of administration thereof |
| US6896899B2 (en) * | 1996-12-31 | 2005-05-24 | Antioxidant Pharmaceuticals Corp. | Pharmaceutical preparations of glutathione and methods of administration thereof |
| WO2002100409A1 (fr) * | 2001-06-11 | 2002-12-19 | Kyowa Hakko Kogyo Co., Ltd. | Compositions anti-inflammatoires et antitussives |
| US20050222250A1 (en) * | 2002-04-16 | 2005-10-06 | Mohiaddin Rezvani | Curcumin for the prevention and/or treatment of tissue damage |
| JP2003321356A (ja) * | 2002-05-01 | 2003-11-11 | Rohto Pharmaceut Co Ltd | 催乳作用を有する組成物 |
| JP2006501303A (ja) * | 2002-10-01 | 2006-01-12 | ミトス・ファーマシューティカルズ・インコーポレーテッド | ニトロキシド放射線防護製剤および使用法 |
| JP4731321B2 (ja) | 2003-07-22 | 2011-07-20 | 協和発酵バイオ株式会社 | ウィルス感染症の予防または治療用組成物 |
-
2005
- 2005-09-02 US US11/574,682 patent/US8067537B2/en active Active
- 2005-09-02 WO PCT/US2005/031364 patent/WO2006028991A2/en active Application Filing
- 2005-09-02 CN CN2005800325924A patent/CN101027078B/zh active Active
- 2005-09-02 AT AT05794086T patent/ATE516040T1/de not_active IP Right Cessation
- 2005-09-02 JP JP2007530409A patent/JP5066448B2/ja active Active
- 2005-09-02 EP EP05794086A patent/EP1789068B1/de active Active
- 2005-09-02 CA CA2578748A patent/CA2578748C/en active Active
-
2007
- 2007-07-16 HK HK07107619.9A patent/HK1099918A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN101027078A (zh) | 2007-08-29 |
| CA2578748A1 (en) | 2006-03-16 |
| CN101027078B (zh) | 2012-07-04 |
| US8067537B2 (en) | 2011-11-29 |
| EP1789068A4 (de) | 2007-10-17 |
| WO2006028991A3 (en) | 2006-04-27 |
| HK1099918A1 (en) | 2007-08-31 |
| JP5066448B2 (ja) | 2012-11-07 |
| EP1789068A2 (de) | 2007-05-30 |
| CA2578748C (en) | 2014-10-14 |
| EP1789068B1 (de) | 2011-07-13 |
| JP2008512381A (ja) | 2008-04-24 |
| WO2006028991A2 (en) | 2006-03-16 |
| US20070259024A1 (en) | 2007-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE458731T1 (de) | Pyrimidin-derivate zur behandlung von anormalem zellwachstum | |
| ATE389649T1 (de) | Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen | |
| ATE513550T1 (de) | Verwendung eines ibat-hemmers zur behandlung oder vorbeugung von verstopfung | |
| ATE512663T1 (de) | Kombination zur behandlung von erkrankungen mit zellproliferation | |
| DE50306850D1 (de) | Benzodiazepin-substituierte piperdine zur verwendung in der behandlung von cardiovaskulären erkrankungen | |
| ATE548035T1 (de) | Formulierungen zur behandlung von lipoprotein- anormalitäten mit einem statin- und einem methylnicotinamid-derivat | |
| ATE414089T1 (de) | Verwendung von rapamycin und dessen derivaten zur behandlung von knochenverlust | |
| ATE448206T1 (de) | Benzochinazolinderivate und ihre verwendung bei der behandlung von knochenerkrankungen | |
| ATE390407T1 (de) | Phenethanolamin-derivate zur behandlung von atemwegserkrankungen | |
| EP1572075A4 (de) | Verfahren zur behandlung von krankheiten in verbindung mit abnormaler kinasewirkung | |
| DE60328517D1 (de) | Neue verwendung von lycopin zur behandlung von erkrankungen im zusammenhang mit androgenwirkung | |
| DE602004031134D1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa | |
| HK1099918A1 (en) | Composition and use for prevention or treatment of stomatitis | |
| ATE499105T1 (de) | Behandlung oder vorbeugung von haut- oder gewebezuständen bei tieren unter verwendung von boryloxypyridylmethanonen | |
| EP1635801A4 (de) | Verfahren zur behandlung und prävention von herzarrhythmie | |
| DE602004022035D1 (de) | Verwendung von pthalide derivativen zur behandlung | |
| ATE460166T1 (de) | Chinazolinderivate und ihre verwendung bei der behandlung von thrombocythämie | |
| ATE362923T1 (de) | 4-(phenylpiperazinylmethyl)benzamidderivate und deren verwendung zur behandlung von schmerzen oder gastrointestinalen erkrankungen | |
| DE602006018725D1 (de) | Amidin-derivate zur verwendung in der vorbeugung oder behandlung von glaukom | |
| DE60325496D1 (de) | Verwendung von dihydroimidazolonen zur behandlung von epilepsie bei hunden | |
| DE60200160D1 (de) | Verwendung von Cilobradine oder pharmazeutisch akzeptablen Salze zur Behandlung oder Prävention von Herzversagen | |
| DE602005016141D1 (de) | S-mirtazapin zur behandlung von hitzewallungen | |
| ATE380551T1 (de) | Verwendung von brimonidine zur behandlung von dementia und morbus parkinson | |
| DE602004012770D1 (de) | Saure chinolin-derivate und ihre verwendung zur prävention und/oder behandlung von erkrankungen im zusammenhang mit hyperglykämie | |
| ATE476974T1 (de) | Verwendung einer kombination von l-carnitin, acetyl l-carnitin und propionyl l-carnitin zur behandlung von oligoasthenoteratospermia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |